| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
RDNT sits in the Life Sciences Tools & Services industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 1.21M | $76.88M | - | |
| CEO | 507.2K | $29.73M | - | |
| COO | 261.2K | - | - | |
| VP | 200.2K | - | - | |
| Dir | 177.0K | $9.54M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 14, 2017 | Hames Norman R56 | Executive Vice President | Sell | 5,000 | $9.71 | $48,541.30 | -1.3% | |
| Dec 13, 2017 | Hames Norman R56 | Executive Vice President | Sell | 10,000 | $9.87 | $98,670.00 | -2.6% | |
| Dec 12, 2017 | Hames Norman R56 | Executive Vice President | Sell | 10,000 | $9.82 | $98,230.00 | -2.5% | |
| Dec 11, 2017 | Hames Norman R56 | Executive Vice President | Sell | 7,500 | $9.68 | $72,567.50 | -1.9% | |
| Dec 6, 2017 | Hames Norman R56 | Executive Vice President | Sell | 5,000 | $9.72 | $48,615.00 | -1.2% | |
| Dec 4, 2017 | Hames Norman R56 | Executive Vice President | Sell | 5,000 | $10.00 | $50,010.00 | -1.2% | |
| Dec 1, 2017 | Crues John V | Medical Director | Sell | 20,000 | $10.08 | $201,530.00 | -3.4% | |
| Nov 30, 2017 | Hames Norman R56 | Executive Vice President | Sell | 900 | $10.50 | $9,450.00 | -0.2% | |
| Nov 27, 2017 | Crues John V | Medical Director | Sell | 20,000 | $9.89 | $197,758.00 | -3.3% | |
| Nov 17, 2017 | Crues John V | Medical Director | Sell | 40,000 | $9.90 | $395,990.00 | -6.2% |